Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 14,327Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 26ASTRAZENECA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

OSIMERTINIB MESYLATE

US Patent Number : 9732058

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208065

Patent Use Code : U-1777

Delist Requested :

Patent Use Description : TREATMENT OF PATIENTS ...

Patent Expiration Date : 2032-07-25

blank

02

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

OSIMERTINIB MESYLATE

US Patent Number : 9732058

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208065

Patent Use Code : U-1777

Delist Requested :

Patent Use Description : TREATMENT OF PATIENTS ...

Patent Expiration Date : 2032-07-25

blank

03

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

OSIMERTINIB MESYLATE

US Patent Number : 8946235

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208065

Patent Use Code : U-1777

Delist Requested :

Patent Use Description : TREATMENT OF PATIENTS ...

Patent Expiration Date : 2032-08-08

blank

04

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

OSIMERTINIB MESYLATE

US Patent Number : 10183020

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208065

Patent Use Code : U-1777

Delist Requested :

Patent Use Description : TREATMENT OF PATIENTS ...

Patent Expiration Date : 2035-01-02

blank

05

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

OSIMERTINIB MESYLATE

US Patent Number : 10183020

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208065

Patent Use Code : U-1777

Delist Requested :

Patent Use Description : TREATMENT OF PATIENTS ...

Patent Expiration Date : 2035-01-02

blank

06

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

OSIMERTINIB MESYLATE

US Patent Number : 10183020

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208065

Patent Use Code : U-2289

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-01-02

blank

07

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

OSIMERTINIB MESYLATE

US Patent Number : 9732058

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208065

Patent Use Code : U-2289

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-07-25

blank

08

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

OSIMERTINIB MESYLATE

US Patent Number : 9732058

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208065

Patent Use Code : U-2289

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-07-25

blank

09

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

OSIMERTINIB MESYLATE

US Patent Number : 8946235

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208065

Patent Use Code : U-2289

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-08-08

blank

10

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

OSIMERTINIB MESYLATE

US Patent Number : 8946235

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208065

Patent Use Code : U-2289

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-08-08

blank